乳酸脱氢酶在胃癌诊治中的研究进展

doi:10.11904/j.issn.1002-3070.2024.03.009

Abstract

Abstract: China is the rank 1st of gastric cancer in the world,and the incidence and mortality of gastric cancer rank the 3rd among various malignant tumors in China.It has been found that tumor cells have their own energy metabolism characteristics.Even in the presence of sufficient oxygen,tumor cells are more inclined to use glycolysis to produce energy,also known as “aerobic glycolysis”.Aerobic glycolysis can lead to an increase in lactate,promoting the acceleration of tumor cell proliferation and invasiveness,and the key enzyme driving this phenomenon is lactate dehydrogenase (LDH).LDH levels are significantly elevated in patients with gastric cancer,and LDH can contribute to the occurrence and development of gastric cancer in many ways.This article will discuss the role of LDH in tumor glycolysis,which is correlated with gastric cancer as well as its clinical application value.It will also discuss the research progress of LDH in targeted therapy for gastric cancer.

Key words: Tumor glycolysis, Lactate dehydrogenase, Prognosis of gastric cancer, Prediction model of gastric cancer

CLC Number:

R735.2

LIAO Jun, LI Chunfeng, XUE Yingwei, ZU Hongliang. Research progress of lactate dehydrogenase in the diagnosis and treatment of gastric cancer[J]. Journal of Practical Oncology, 2024, 38(3): 200-206.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.11904/j.issn.1002-3070.2024.03.009

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2024/V38/I3/200

References

1 Maomao C,He L,Dianqin S,et al.Current cancer burden in China:epidemiology,etiology,and prevention[J].Cancer Biol Med,2022,19(8):1121-1138.
2 Fukushi A,Kim HD,Chang YC,et al.Revisited metabolic control and reprogramming cancers by means of the Warburg effect in tumor cells[J].Int J Mol Sci,2022,23(17):10037.
3 Abdel-Wahab AF,Mahmoud W,Al-Harizy RM.Targeting glucose metabolism to suppress cancer progression:prospective of anti-glycolytic cancer therapy[J].Pharmacol Res,2019,150:104511.
4 Koukourakis MI,Giatromanolaki A.Warburg effect,lactate dehydrogenase,and radio/chemo-therapy efficacy[J].Int J Radiat Biol,2019,95(4):408-426.
5 Kocianova E,Piatrikova V,Golias T.Revisiting the Warburg effect with focus on lactate[J].Cancers (Basel),2022,14(24):6028.
6 Khan AA,Allemailem KS,Alhumaydhi FA,et al.The biochemical and clinical perspectives of lactate dehydrogenase:an enzyme of active metabolism[J].Endocr Metab Immune Disord Drug Targets,2020,20(6):855-868.
7 Goldberg E,Eddy EM,Duan C,et al.LDHC:the ultimate testis-specific gene[J].J Androl,2010,31(1):86-94.
8 Zhang Y,Zhang T,Zhao Y,et al.Lactate dehydrogenase D serves as a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma[J].BMC Cancer,2023,23(1):759.
9 Semenza GL,Jiang BH,Leung SW,et al.Hypoxia response elements in the aldolase A,enolase 1,and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1[J].J Biol Chem,1996,271(51):32529-32537.
10 Shim H,Dolde C,Lewis BC,et al.c-Myc transactivation of LDH-A:implications for tumor metabolism and growth[J].Proc Natl Acad Sci U S A,1997,94(13):6658-6663.
11 Shi M,Cui J,Du J,et al.A novel KLF4/LDHA signaling pathway regulates aerobic glycolysis in and progression of pancreatic cancer[J].Clin Cancer Res,2014,20(16):4370-4380.
12 Jiang W,Zhou F,Li N,et al.FOXM1-LDHA signaling promoted gastric cancer glycolytic phenotype and progression[J].Int J Clin Exp Pathol,2015,8(6):6756-6763.
13 Okada K,Fujiwara Y,Takahashi T,et al.Overexpression of forkhead box M1 transcription factor (FOXM1)is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer[J].Ann Surg Oncol,2013,20(3):1035-1043.
14 Hu S,Jiang Q,Luo D,et al.miR-200b is a key regulator of tumor progression and metabolism targeting lactate dehydrogenase A in human malignant glioma[J].Oncotarget,2016,7(30):48423-48431.
15 Jin L,Chun J,Pan C,et al.Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis[J].Oncogene,2017,36(27):3797-3806.
16 Shao M,Zhang J,Zhang J,et al.SALL4 promotes gastric cancer progression via hexokinase II mediated glycolysis[J].Cancer Cell Int,2020,20:188.
17 Jiang Z,Wang X,Li J,et al.Aldolase A as a prognostic factor and mediator of progression via inducing epithelial-mesenchymal transition in gastric cancer[J].J Cell Mol Med,2018,22(9):4377-4386.
18 Yang T,Shu X,Zhang HW,et al.Enolase 1 regulates stem cell-like properties in gastric cancer cells by stimulating glycolysis[J].Cell Death Dis,2020,11(10):870.
19 Shiroki T,Yokoyama M,Tanuma N,et al.Enhanced expression of the M2 isoform of pyruvate kinase is involved in gastric cancer development by regulating cancer-specific metabolism[J].Cancer Sci,2017,108(5):931-940.
20 Barron CC,Bilan PJ,Tsakiridis T,et al.Facilitative glucose transporters:implications for cancer detection,prognosis and treatment[J].Metabolism,2016,65(2):124-139.
21 Liu X,Zou X,Zhou Y,et al.LDHA and LDHB overexpression promoted the Warburg effect in malignantly transformed GES-1 cells induced by N-nitroso compounds[J].Food Chem Toxicol,2023,180:114007.
22 Jin S,Yin E,Feng C,et al.Regulating tumor glycometabolism and the immune microenvironment by inhibiting lactate dehydrogenase with platinum(iv)complexes[J].Chem Sci,2023,14(31):8327-8837.
23 Chen X,Liu L,Kang S,et al.The lactate dehydrogenase (LDH)isoenzyme spectrum enables optimally controlling T cell glycolysis and differentiation[J].Sci Adv,2023,9(12):eadd9554.
24 Sharma D,Singh M,Rani R.Role of LDH in tumor glycolysis:regulation of LDHA by small molecules for cancer therapeutics[J].Semin Cancer Biol,2022,87:184-195.
25 Zhang Y,Lin S,Chen Y,et al.LDH-Apromotes epithelial-mesenchymal transition by upregulating ZEB2 in intestinal-type gastric cancer[J].Onco Targets Ther,2018,11:2363-2373.
26 Ping W,Senyan H,Li G,et al.Increased lactate in gastric cancer tumor-infiltrating lymphocytes is related to impaired T cell function due to miR-34a deregulated lactate dehydrogenase a[J].Cell Physiol Biochem,2018,49(2):828-836.
27 Jin HF,Wang JF,Shao M,et al.Down-regulation of miR-7 in gastric cancer is associated with elevated LDH-A expression and chemoresistance to Cisplatin[J].Front Cell Dev Biol,2020,8:555937.
28 Wang XH,Jiang ZH,Yang HM,et al.Hypoxia-induced FOXO4/LDHA axis modulates gastric cancer cell glycolysis and progression[J].Clin Transl Med,2021,11(1):e279.
29 Han ZR,Jiang XL,Fan WC.LAMC1 is related to the poor prognosis of patients with gastric cancer and facilitates cancer cell malignancies[J].Neoplasma,2021,68(4):711-718.
30 Zhu W,Ma L,Qian J,et al.The molecular mechanism and clinical significance of LDHA in HER2-mediated progression of gastric cancer[J].Am J Transl Res,2018,10(7):2055-2067.
31 da Silva EL,Mesquita FP,Aragão DR,et al.Mebendazole targets essential proteins in glucose metabolism leading gastric cancer cells to death[J].Toxicol Appl Pharmacol,2023,475:116630.
32 Augoff K,Hryniewicz-Jankowska A,Tabola R.Lactate dehydrogenase 5:an old friend and a new hope in the war on cancer[J].Cancer Lett,2015,358(1):1-7.
33 Chen WS,Huang ZX,Zhang HH,et al.Lactate dehydrogenase and risk of readmission with gastric cancer:a propensity score matching analysis[J].J Invest Surg,2023,36(1):2172488.
34 Kostakis ID,Vaiopoulos AG,Philippou A,et al.Preoperative serum lactate dehydrogenase levels in colorectal and gastric cancer:a hospital-based case-control study[J].Biomark Med,2013,7(1):131-137.
35 Comandatore A,Franczak M,Smolenski RT,et al.Lactate Dehydrogenase and its clinical significance in pancreatic and thoracic cancers[J].Semin Cancer Biol,2022,86(Pt 2):93-100.
36 Zhao LJ,Liu FX,Wang XP,et al.Analysis of clinical prognosis of 68 patients with gastric mucosa-associated lymphoid tissue lymphoma[J].Zhonghua Yi Xue Za Zhi,2020,100(32):2511-2517.
37 Wu Z,Liu D,Deng F.The role of vitamin D in immune system and inflammatory bowel disease[J].J Inflamm Res,2022,15:3167-3185.
38 Zhou Q,Lan X,Li N,et al.Analysis of prognostic factors and design of prognosis model for patients with stage IV gastric cancer following first-line palliative chemotherapy[J].Cancer Manag Res,2020,12:10461-10468.
39 Ruzzo A,Graziano F,Bagaloni I,et al.Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab[J].Gastric Cancer,2020,23(6):1064-1074.
40 Hao LS,Liu Q,Tian C,et al.Correlation and expression analysis of hypoxia-inducible factor 1α,glucose transporter 1 and lactate dehydrogenase 5 in human gastric cancer[J].Oncol Lett,2019,18(2):1431-1441.
41 Chen J,Zou X.Prognostic significance of lactate dehydrogenase and its impact on the outcomes of gastric cancer:a systematic review and meta-analysis[J].Front Oncol,2023,13:1247444.
42 Wang ZX,Yang LP,Qiu MZ,et al.Prognostic value of preoperative serum lactate dehydrogenase levels for resectable gastric cancer and prognostic nomograms[J].Oncotarget,2016,7(26):39945-39956.
43 Namikawa T,Ishida N,Tsuda S,et al.Prognostic significance of serum alkaline phosphatase and lactate dehydrogenase levels in patients with unresectable advanced gastric cancer[J].Gastric Cancer,2019,22(4):684-691.
44 Xie Z,Zhou H,Wang L,et al.The Significance of the preoperative lactate dehydrogenase/albumin ratio in the prognosis of colon cancer:a retrospective study[J].PeerJ,2022,10:e13091.
45 Chen Q,Li GL,Zhu HQ,et al.The neutrophil-to-lymphocyte ratio and lactate dehydrogenase combined in predicting liver metastasis and prognosis of colorectal cancer[J].Front Med (Lausanne),2023,10:1205897.
46 Peng RR,Liang ZG,Chen KH,et al.Nomogram based on lactate dehydrogenase-to-albumin ratio (LAR)and platelet-to-lymphocyte ratio (PLR)for predicting survival in nasopharyngeal carcinoma[J].J Inflamm Res,2021,14:4019-4033.
47 Aday U,Tatli F,Akpulat FV,et al.Prognostic significance of pretreatment serum lactate dehydrogenase-to-albumin ratio in gastric cancer[J].Contemp Oncol (Pozn),2020,24(3):145-149.
48 Makley LN,Gestwicki JE.Expanding the number of ′druggable′ targets:non-enzymes and protein-protein interactions[J].Chem Biol Drug Des,2013,81(1):22-32.
49 Conners R,Schambach F,Read J,et al.Mapping the binding site for gossypol-like inhibitors of Plasmodium falciparum lactate dehydrogenase[J].Mol Biochem Parasitol,2005,142(2):137-148.
50 Le A,Cooper CR,Gouw AM,et al.Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression[J].Proc Natl Acad Sci U S A,2010,107(5):2037-2042.
51 Liu R,Wang X,Shen Y,et al.Long non-coding RNA-based glycolysis-targeted cancer therapy:feasibility,progression and limitations[J].Mol Biol Rep,2021,48(3):2713-2727.
52 Yang WQ,Zhang Y.RNAi-mediated gene silencing in cancer therapy[J].Expert Opin Biol Ther,2012,12(11):1495-1504.
53 Manjunath LE,Singh A,Som S,et al.Mammalian proteome expansion by stop codon readthrough[J].Wiley Interdiscip Rev RNA,2023,14(2):e1739.
54 Aldosari BN,Alfagih IM,Almurshedi AS.Lipid nanoparticles as delivery systems for RNA-based vaccines[J].Pharmaceutics,2021,13(2):206.
55 D′Andrea F,Vagelli G,Granchi C,et al.Synthesis and biological evaluation of bew glycoconjugated LDH inhibitors as anticancer agents[J].Molecules,2019,24(19):3520.
56 Li Petri G,El Hassouni B,Sciarrillo R,et al.Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter,and preclinical activity of new anti-LDH-A compounds[J].Br J Cancer,2020,123(4):644-656.
57 Giovannetti E,Leon LG,Gómez VE,et al.A specific inhibitor of lactate dehydrogenase overcame the resistance toward gemcitabine in hypoxic mesothelioma cells,and modulated the expression of the human equilibrative transporter-1[J].Nucleosides Nucleotides Nucleic Acids,2016,35(10-12):643-651.
58 Zhao Z,Han F,Yang S,et al.Oxamate-mediated inhibition of lactate dehydrogenase induces protective autophagy in gastric cancer cells:involvement of the Akt-mTOR signaling pathway[J].Cancer Lett,2015,358(1):17-26.
59 Yang Y,Chong Y,Chen M,et al.Targeting lactate dehydrogenase a improves radiotherapy efficacy in non-small cell lung cancer:from bedside to bench[J].J Transl Med,2021,19(1):170.
60 Kooshki L,Mahdavi P,Fakhri S,et al.Targeting lactate metabolism and glycolytic pathways in the tumor microenvironment by natural products:a promising strategy in combating cancer[J].BioFactors,2022,48(2):359-383.
61 Song S,Chen Q,Li Y,et al.Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma[J].Gut,2021,70(12):2238-2248.
62 Oshima N,Ishida R,Kishimoto S,et al.Dynamic imaging of LDH inhibition in tumors reveals rapid in vivo metabolic rewiring and vulnerability to combination therapy[J].Cell Rep,2020,30(6):1798-1810.
63 Han JH,Lee EJ,Park W,et al.Natural compounds as lactate dehydrogenase inhibitors:potential therapeutics for lactate dehydrogenase inhibitors-related diseases[J].Front Pharmacol,2023,14:1275000.
64 Akbari B,Baghaei-Yazdi N,Bahmaie M,et al.The role of plant-derived natural antioxidants in reduction of oxidative stress[J].Biofactors,2022,48(3):611-633.
65 Han JH,Kim M,Kim HJ,et al.Targeting lactate dehydrogenase A with catechin resensitizes SNU620/5FU gastric cancer cells to 5-Fluorouracil[J].Int J Mol Sci,2021,22(10):5406.
66 Zhao M,Wei F,Sun G,et al.Natural compounds targeting glycolysis as promising therapeutics for gastric cancer:a review[J].Front Pharmacol,2022,13:1004383.

[1]	YANG Peng, LUO Jinmei, LUO Ping, XIE Xiaobo. An immune score model based on immune cell infiltration predicts the effects of immunotherapy and prognosis of early gastric cancer [J]. Journal of Practical Oncology, 2024, 38(2): 121-130.
[2]	GAO Chaofeng, ZHAO Zekun, WEI Fengxian, SUN Yuan, ZHOU Zhiming, XU Xiaodong. Research progress on perioperative nutritional management for gastric cancer [J]. Journal of Practical Oncology, 2023, 37(6): 519-523.
[3]	YANG Ju, LIU Qin, LIU Baorui, WEI Jia. Gastric cancer-associated cancer-testis antigen screening and immune infiltration analysis [J]. Journal of Practical Oncology, 2022, 36(6): 495-501.
[4]	XU Wei, LIU Haipeng, WANG Wenjie, WANG Zhou, LI Yuanyuan, SHEN Yimin, CHEN Xiao. Research progress on the causes and prevention measures of cholecystolithiasis after gastric cancer surgery [J]. Journal of Practical Oncology, 2022, 36(6): 561-565.
[5]	ZHAO Yaru, WU Yun. Research status of common biomarkers and corresponding targeted therapy for gastric cancer [J]. Journal of Practical Oncology, 2022, 36(5): 483-488.
[6]	ZHI Lianghui, LIU Wei, LI Wei, ZHEN Sihu, JIAO Xilin. Mechanism of lncRNA-ATB mediated epithelial mesenchymal transition in the progression of gastric cancer [J]. Journal of Practical Oncology, 2022, 36(3): 208-213.
[7]	ZHANG Ning, LIN Liuya, LI Sifan, ZHU Meng. Effects of miR-106a targeting TIMP2 on proliferation,metastasis and EMT of human gastric cancer [J]. Journal of Practical Oncology, 2022, 36(2): 105-110.
[8]	WANG Hongying, LI Yan, HAN Xinhao, WEI Xiaoli, JIA Huixun, YUAN Wenjuan, ZHANG Qiuju. Construction and validation of a risk model for early diagnosis and prognosis of gastric cancer based on immune-related lncRNAs [J]. Journal of Practical Oncology, 2022, 36(2): 119-126.
[9]	ZHAO Baoshan, LIANG Guanying, XU Shengjie, QIAO Hui, CHEN Hongxia, MA Ying, JU Xueping, WANG Lin. Analysis of the correlation between PELP1 expression and gastric cancer progression and prognosis [J]. Journal of Practical Oncology, 2022, 36(1): 31-36.
[10]	WU Liting, LI Dabing, DENG Xiaoxia, LI Baisong. Trend and prediction of gastric cancer burden in Beibei district of Chongqing city from 2013 to 2020 [J]. Journal of Practical Oncology, 2021, 35(6): 495-499.
[11]	CHEN Yixin, SUN Yihua, CHENG Yangyang, HE Kaitong, GUO Ting. Relationship between preoperative inflammation-related indicators and prognosis of patients with resectable gastric cancer [J]. Journal of Practical Oncology, 2021, 35(6): 517-522.
[12]	YU Yuanyuan, MENG Qianhao, WANG Guangyu. Dilemma and future direction of gastric cancer immunotherapy [J]. Journal of Practical Oncology, 2021, 35(6): 552-556.
[13]	YIN Songxiang. Expression of Copine-8 in gastric cancer and its correlations with clinicopathological features and prognosis [J]. Journal of Practical Oncology, 2020, 34(5): 430-435.
[14]	LI Jian, MA Qi, REN Jin, HU Shengjuan. Research progress on influencing factors of gastric cancer [J]. Journal of Practical Oncology, 2020, 34(5): 466-470.
[15]	YAO Yang, ZHANG Yanqiao. Mechanism and recent progress of gastric cancer in immunological checkpoint inhibitors [J]. Journal of Practical Oncology, 2019, 33(4): 371-375.

Research progress of lactate dehydrogenase in the diagnosis and treatment of gastric cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments